This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Watanakunakorn, C. Articles by Glotzbecker, C. Search for Related Content PubMed PubMed Citation Articles by Watanakunakorn, C. Articles by Glotzbecker, C.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 January; 11(1): 88-91
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Comparative In Vitro Activity of Nafcillin, Oxacillin, and Methicillin in Combination with Gentamicin and Tobramycin Against Enterococci

Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267

ABSTRACT

The in vitro activity of nafcillin, oxacillin, and methicillin alone and in combination with gentamicin and tobramycin against 30 strains of enterococci was investigated. The penicillinase-resistant penicillins were less active than penicillin and ampicillin against the enterococci. Nafcillin was more active than oxacillin and methicillin. Sixty-six percent of strains were inhibited by nafcillin at 6.25 µg/ml, but none was inhibited by oxacillin and methicillin at the same concentration. At 12.5 µg/ml, 83, 16, and 0% were inhibited by nafcillin, oxacillin, and methicillin, respectively. By using a variety of criteria and analyses, it was shown that none of the antibiotic combinations studied demonstrated enhanced killing of all strains of enterococci. Nafcillin-gentamicin was the best combination, and enhanced killing was demonstrated against most strains. Oxacillin was more effective than methicillin when combined with gentamicin. Tobramycin was probably less effective than gentamicin in combination with the penicillinase-resistant penicillins against enterococci.